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EntryChikungunya virus (CHIKV) is an alphavirus responsible for a number of large outbreaks. Here we describe
the efﬁcient incorporation of CHIKV envelope glycoproteins into lentiviral and rhabdoviral particles. Vectors
pseudotyped with CHIKV envelope proteins efﬁciently transduced many cell types from different species.
However, hematopoietic cell types were either partially or completely refractory. A mutation in E1 (A226V)
has been linked with expansion of tropism for mosquito species, although differences in in vitro infection of
mosquito cell lines have not been noted. However, pseudovirion infectivity assays detected subtle differences
in infection of mosquito cells, suggesting an explanation for the changes in mosquito tropism. The presence
of C-type lectins increased CHIKV pseudotyped vector infectivity, but not infection of refractory cells,
suggesting that they act as attachment factors rather than primary receptors. CHIKV pseudotypes will serve
as an important tool for the study of neutralizing antibodies and the analysis of envelope glycoprotein
functions.
© 2009 Elsevier Inc. All rights reserved.Introduction
Chikungunya virus (CHIKV) is an alphavirus belonging to the To-
gaviridae family and was ﬁrst isolated in 1952 from a febrile individual
in Tanzania (Peters, 1990; Strauss, 1986). CHIKV is transmitted to
humans by several species of mosquitoes, with Aedes aegypti and A.
albopictus being the twomain vectors. Acute infection is characterized
by a painful polyarthralgia, high fever, asthenia, headache, vomiting,
rash and myalgia (Bodenmann and Genton, 2006; Peters, 1990;
Pialoux et al., 2007). In many patients, a chronic and incapacitating
arthralgia persists for months. During the last 50 years, there have
been numerous CHIKV outbreaks in East and Southern Africa and in
Southeast Asia (Schuffenecker et al., 2006). Though generally not fatal,
CHIKV has sickened 1.6 million people in the Indian Ocean region
since 2005 (Charrel et al., 2007). Three distinct phylogroups have
been described based on E1 sequence of different CHIKV isolates, and
microevolution of virus strains has been associated with infection
outbreaks (Schuffenecker et al., 2006). In particular, changes in the
envelope glycoproteins (gps) of the virus have been described that
affect infectivity in different mosquito species. A single change attute, 270 Masonic Avenue, San
mons).
ll rights reserved.position 226 of E1 protein has been associated with the adaptation of
the virus to more efﬁciently infect and be transmitted by A. albopictus,
which is thought to be the major vector of the large scale CHIKV
epidemic on La Reunion Island (Tsetsarkin et al., 2007; Vazeille et al.,
2007), as well as a recent outbreak in Italy (Bonilauri et al., 2008). This
change has also been shown to modulate cholesterol requirement for
infection of insect cells by CHIKV (Tsetsarkin et al., 2007), as well as
other alphaviruses (Ahn et al., 1999; Lu et al., 1999).Whether there is a
correlation between cholesterol requirements and CHIKV ﬁtness
increase in A. albopictus remains unknown. The adaptation of the
virus to the broadly distributed mosquito species A. albopictus
increases the potential of CHIKV to extend its range further into
Europe and America (Tsetsarkin et al., 2007).
Alphaviruses are small enveloped, single stranded, positive
polarity RNA viruses (Peters, 1990). They attach to poorly character-
ized receptors on many different cell types in various species. Viral
entry generally occurs through receptor-mediated endocytosis, and
fusion is dependent on endosomal acidiﬁcation (DeTulleo and
Kirchhausen, 1998; Kolokoltsov et al., 2006; Marsh and Helenius,
2006; Marsh et al., 1984). CHIKV particles contain three structural
proteins: glycosylated El and E2 envelope proteins, embedded in the
viral membrane, and a non-glycosylated nucleocapsid protein. Based
on similarity to other alphaviruses, E2 mediates receptor attachment,
while E1 is a class II viral fusion protein. A third glycoprotein, E3, is not
associated withmature virions but released into culture ﬂuids (Simizu
Fig. 1. Chikungunya virus envelope protein expression. Western blot was performed
using a mix of human sera from CHIKV infected individuals to detect protein expression
in pseudotype producer 293T cell lysates and concentrated HIV-pseudotypes bearing
CHIKV wt and E1A226V mutant envelope glycoproteins and VSV-G protein. The
positions of molecular mass markers (kDa) are shown on the right.
34 B. Salvador et al. / Virology 393 (2009) 33–41et al., 1984), while 6K protein, a membrane-associated peptide created
by cleavage of the polyprotein to release E2 and E1, is incorporated
into particles at a low level (Gaedigk-Nitschko and Schlesinger, 1990;
Lusa et al., 1991). There is a critical lack of knowledge of CHIKV
biology, contrasting with related model alphaviruses like Sindbis
virus (SINV), Semliki Forest virus (SFV), and Ross River virus (RRV).
In particular, little is known about the interaction of CHIKV (and of
most alphaviruses) with human primary cells. CHIK virus isolates
from La Reunion outbreak have been described to infect in vitro
primary ﬁbroblasts, and, to a lower extent monocyte-derived
macrophages, but not primary periferal blood mononuclear cells,
primary lymphocytes and monocytes, nor monocyte-derived den-
dritic cells (Sourisseau et al., 2007). Studies using live CHIKV have
been limited partially because they must be performed at biosafety
level 3 (Anon, 2007).
Pseudotyped viruses have important applications as tools for the
study of viral glycoprotein function and attachment/entry processes.
They can also be used to analyze immune responses and the
development of neutralizing antibodies. Furthermore, they can have
utility as vaccines, as well as vectors for gene transfer and gene
therapy. In particular, due to CHIKV's apparent preference for muscle
satellite cells (Ozden et al., 2007), CHIKVmay be useful for therapeutic
gene replacement of muscle disease such as muscular dystrophy.
Pseudotyped viruses incorporate heterologous viral gps thus acquir-
ing the host range of the virus fromwhich these gps are derived. Early
steps in infection, such as receptor binding, membrane fusion, and
entry, are determined solely by properties of the nonrelated envelope
protein. Also virus envelope gps are the primary targets of neutralizing
antibody responses. The epitopes recognized differ sufﬁciently
between virus subtypes and species to distinguish viruses and provide
an important basis for disease diagnosis.
Here we describe the successful development and validation of
CHIKV pseudovirions. We have assessed CHIKV protein incorporation
as well as sensitivity to sera from CHIKV infected individuals.
Recapitulation of the cell tropism of the pseudovirions has been
performed allowing us to describe several refractory cell lines. We also
demonstrate that mutations in E1 glycoprotein mediate cellular
tropism differences in mosquito cells. These pseudovirions permit
analysis of the host range and function of the Chikungunya virus gps
allowing future work that will help to elucidate the pathogenesis and
tropism of this as yet poorly characterized virus. They will also
improve laboratory safety and security as they can be handled at
biosafety level 2.
Results
Chikungunya envelope glycoproteins are incorporated into
lentiviral pseudoparticles
In order to determine if CHIKV envelope gps were incorporated
into HIV pseudoparticles, 293T cells were transfected with pNL-luc, a
lentiviral vector encoding luciferase, and a plasmid encoding the
CHIKV envelope proteins with and without a point mutation in E1
(A226V) involved in mosquito tropism changes (Tsetsarkin et al.,
2007). As controls, 293T cells were also transfected with plasmids
encoding vesicular stomatitis virus (VSV) G protein and the pNL-luc
vector. After 40 h, the virions obtained were concentrated by
ultracentrifugation and the transfected cells were lysed. Both the
concentrated virions and the cell lysates were analyzed by Western
blot using a mix of 3 different sera from CHIKV infected individuals.
CHIKV proteins E1 (52 kDa) and E2 (56 kDa) (that nearly co-migrate
in the gel) as well as the p62 (62 kDa) precursor proteinwere detected
in both wild type and A226Vmutant cell lysates but not in the control
VSV-G cell lysate (Fig. 1). Two nonspeciﬁc bands of approximately 80
and 50 kDa respectively were also observed in all the cell lysates
samples (Fig. 1). Similar amounts of CHIKV envelope gps were alsodetected in the concentrated wild type and mutant CHIKV pseudo-
particles indicating that lentiviral particle production was roughly
equivalent in both transfections (Fig. 1). Thus, CHIKV gps are
efﬁciently produced in 293T cells and are successfully incorporated
into the HIV pseudoparticles. Also, the result demonstrates that the
CHIKV proteins incorporated into the pseudoparticles are efﬁciently
recognized by antibodies present in the sera of individuals with a prior
history of CHIKV infection. Additionally, immunoﬂuorescence studies
using anti-CHIKV positive sera on live cells suggested the CHIKV gps
were efﬁciently expressed on the surface of transfected cells (data not
shown). Incorporation into murine leukemia virus (MLV)-based
retroviral particles was also demonstrated with titers in RD muscle
cell line of 9.8×106 FFU/ml for CHIKV envelope and 1.3×107 FFU/ml
for VSV-G.
CHIKV pseudovirus infection is inhibited by sera from
infected individuals
As expected from previous studies with replication competent
CHIKV (Ozden et al., 2007), pseudovirions carrying CHIKV envelope
efﬁciently infected the muscle derived RD cells (1.4×107 FFU/ml). To
further characterize the speciﬁcity of CHIKV pseudotype infection, we
tested the ability of sera from individuals previously infected with
CHIKV to neutralize wild type and A226V E1 mutant pseudovirion
infectivity in RD cells. Similar titers of wild type and mutant CHIKV
pseudovirions (15 pg of p24) were incubated with either serum from
9 different infected individuals or a control serum from an uninfected
individual at various dilutions and then used to infect RD cells. All sera
from CHIKV infected patients were able to inhibit RD cell infection by
either wild type or mutant envelope pseudotypes with similar
efﬁciency (Table 1 and Supplementary Fig. 1). Inhibition was dose
dependent whereas a negative control serum had little effect,
although partial neutralization was seen at the highest concentration
(Table 1 and Supplementary Fig. 1). Similar data was obtained with
four additional, geographically diverse, negative control sera (data not
Table 1
Neutralization of CHIKV pseudovirions.
Sera CHIK WTa CHIK A226Va
IC50 IC90 IC50 IC90
1 3030 455 4348 526
2 3125 417 3846 500
3 3125 455 3704 500
3317 6250 833 7692 1000
4102 4545 588 6250 714
4743 6667 833 8333 1000
92869 909 71 1000 71
92958 2083 133 1818 137
93137 2128 161 2564 133
Controlb 56 b30 38 b30
a The values represent the serum dilutions interpolated from the dose–response
curves as inhibiting 50 or 90% of luciferase read-out relative to control assays carried out
in the absence of serum. b indicates no neutralization at the lowest dilution of serum
tested (1 in 30).
b Representative uninfected negative control serum.
Table 2
HIV pseudovirus titers determined by GFP expression.
Name Cell typea Virus titer (FFU/ml)b
CHIKV ENV VSV-G
RD Muscle 1.4×107 2.5×107
HT1080 Fibrosarcoma 1.4×107 1.9×107
SW480 Colorectal 1.2×107 2.4×107
293T Kidney epithelial 7.7×106 2.6×107
NP2 Brain 3.1×107 2.4×107
HeLa Cervical carcinoma epithelial 5.0×106 6.7×106
Hos Bone 2.6×107 4.1×107
A549 Alveolar epithelial 1.7×107 3.0×107
Keratinocytes Primary keratinocytes 7.4×107 8.3×107
Endothelial Primary endothelial cells 2.6×107 3.4×107
Muscle Primary muscle cells 3.4×107 ND
Name Cell typea Virus titer (FIU/ml)c
CHIKV ENV VSV-G
THP1 Monocytes 4.0×104 3.1×105
BTHP1 B cell line –d 1.1×105
4 5
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control pseudotypes carrying VSV-G (data not shown). These results
demonstrate that entry of the pseudotyped viruses is mediated by the
CHIKV gps and validates their utility to evaluate CHIKV antibody
neutralization capacity.
CHIKV pseudovirus infection is inhibited by lysosomotropic agents
The effects of lysosomotropic agents in pseudovirion infection
were studied to further analyze the CHIKV envelope-mediated entry
process. These agents are known to raise the pH of the endosomal
compartment, efﬁciently blocking infection by viruses dependent on
a low-pH step for entry (Marsh and Helenius, 1989; Miller and
Lenard, 1980; Ohkuma and Poole, 1978). We chose RD cells as targets
for infection because they are susceptible to infection by both VSV-G
lentiviral pseudotypes that exhibit pH-dependent entry and ampho-
tropic MLV (MLV-A) envelope lentiviral pseudotypes, whose entry is
pH-independent (McClure et al., 1990). Baﬁlomicin A, an inhibitor of
vacuolar H+-ATPases responsible for acidifying endosomes, inhibi-
ted transduction of RD cells by both CHIKV and VSV-G pseudotypes
(Fig. 2). In contrast, no inhibition was detected in MLV-A pseudotype
challenged cells, even with high baﬁlomicin A concentrations (Fig. 2)
indicating that the inhibitory effects of baﬁlomicin A did not result
from post-entry inhibition of HIV core replication. Similar results
were obtained with the acidotropic weak bases ammonium chloride
(NH4Cl) and chloroquine (data not shown). Together, these data
indicate that CHIKV envelope-mediated entry is dependent on
endosomal acidiﬁcation.Fig. 2. Effect of lysosomotropic agents on pseudotype transduction. Baﬁlomicin A
inhibition of RD cell transduction by MLV-A env (triangles), CHIKV gps (squares) and
VSV-G (dots) pseudotypes. Results are expressed as percentage of no drug and
represent the means of duplicate wells. The data is representative of four experiments.Analysis of CHIKV pseudovirus tropism in mammalian cells
A panel of human adherent and non-adherent cell lines, primary
human cells and non-human cell lines was used to characterize the
tropism of CHIKV pseudotyped viruses (Table 2). Parallel infections
were carried out with HIV particles produced in the absence of a viral
envelope protein as a negative control and VSV-G pseudotyped
particles, which display a very broad tropism, to distinguish from
possible post-entry blockage effects. In this case the HIV vector used
was pNL-gfp that carries the Aequorea victoria green ﬂuorescent
protein (GFP) gene as a reporter. Virus input of ultracentrifuge
pelleted samples was normalized by p24 content prior to infection.
The viral titers obtained on the individual cell lines varied quite
dramatically (Table 2), but in general this variation was consistent
between CHIKV envelope and VSV-G pseudovirions (Fig. 3). GFP
expression showed that most cell types listed in Table 2 were
permissive for CHIKV pseudotypes demonstrating the wide cellular
tropism conferred by CHIKV envelope gps (Fig. 3). However most
hematopoietic cell lines were either completely or partially refractory
to CHIKV pseudotype infection. Primary, PHA/IL-2 stimulated PBLs
were also not infectible by CHIKV pseudovirions. For reasons of better
detection, vectors encoding murine CD24 were used in the place of
GFP. PBLs were over 99% CD3 positive, and could be easily transduced
with pseudovirions bearing VSV-G, resulting in 10.3% of cells staining
positive for murine CD24. In contrast, even using 10-fold higher
inoculum, CHIKV failed to give any signiﬁcant transduction above that
for no envelope controls (0.25 and 0.15% respectively).HEL Erytroleukemia 3.7×10 2.5×10
H9 CD4 T cell line –d 1.3×105
MEG-01 Megakaryoblast 2.1×104 6.1×105
U937 Promonocytic 1.6×104 1.5×105
221-CD4 Monkey T cell line –d 1.7×105
Macrophages Primary monocyte-derived
macrophages
3.9×104 6.4×104
MDBK Bovine kidney 4.5×104 8.7×104
3T3 Mouse ﬁbroblast 8.9×104 1.2×105
vEPT Rabbit kidney 5.0×104 1.9×105
SK-RST Pig kidney 1.2×105 5.2×105
Vero Monkey kidney 9.0×104 2.0×105
BHK21 Hamster kidney 1.3×105 3.7×105
NRK Rat kidney 1.7×105 5.1×105
CEF Chicken embryo ﬁbroblasts 1.2×105 1.3×105
QT6 Quail ﬁbroblast 8.1×104 7.5×105
C6 Rat brain 3.0×105 7.3×105
L2 Rat lung 9.1×104 2.0×105
Results are representative of at least 2 independent experiments.
a Cells are human unless otherwise stated.
b Titer obtained by counting GFP positive cells under ﬂuorescence microscope.
c Titer obtained by sample FACS analysis.
d FACS data below negative (b1×104 FIU/ml).
Fig. 3. Relative cell tropism of CHIKV pseudotypes. GFP expressionwas used for parallel titration of CHIKV and VSV-G pseudotypes in a panel of cell types. Relative CHIKV pseudotype
titer as compared to VSV-G pseudotype titer in each cell type is shown. The dotted line indicates 100% infectivity for VSV-G pseudotypes. Data represent the average of at least two
independent experiments.
Fig. 4. Pseudotype infectivity for wt and A226V CHIKV envelopes in mammalian cells.
Equal amounts (normalized by p24 ELISA) of pseudotypes bearing CHIKV envelope wt
or 226Vmutant were titrated in parallel in different cell types. GFP titer was determined
by ﬂow cytometry. Each pseudotype was tested in triplicate for each cell type and error
bars represent standard deviations (SDs). Differences in viral titers were analyzed by
pairwise t-tests. Diamond indicates PN0.3.
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that there might be a correlation between cell adhesion and
susceptibility. However, no difference in infectivity was found
between adherent and suspension cultured 293FR cells (data not
shown) indicating that the susceptibility to CHIKV pseudotype
infection is most likely independent of cell adhesion. The titers of
the VSV-G pseudotypes were consistently higher than that of the
CHIKV envelope except in the case of human NP2 glioma cell line and
chicken embryo ﬁbroblasts in which CHIKV envelope pseudotypes
titers were respectively 26% and 35% higher than those of VSV-G
pseudotypes (Fig. 3). This is consistent with a strong tropism for
ﬁbroblasts and the CNS observed in in vivo models of CHIKV infection
(Couderc et al., 2008). Endothelial human primary cells and human
primary keratinocytes were also susceptible to CHIKV pseudotype
infection (Fig. 3). In a separate experiment, fetal primary CD146+
myoblasts were also highly susceptible to CHIKV pseudotypes, with a
titer of 4.3×107 FFU/ml. CD146 is a marker for myoblasts (Cerletti et
al., 2006), and thus these results are consistent with previous ﬁndings
that CHIKV infects muscle precursor cells (Ozden et al., 2007). It has
been described that monocytes are insensitive to CHIKV infection
while human primary macrophages are productively infected
(Sourisseau et al., 2007). Differentiation of THP1 monocytes into
macrophages using retinoic acid (Hickstein et al.,1992) resulted in a 4-
fold increase in CHIKV pseudotype susceptibility (data not shown)
suggesting that CHIKV inability to infect monocytes may be at least
partially related to a lack of efﬁcient entry that is overcome by the
changes induced after the macrophage differentiation process. HIV
does not replicate efﬁciently in primarymonocytes, thuswedeveloped
VSV-based pseudovirions (Matsuura et al., 2001) in order to study
CHIKV envelope-mediated monocyte infection. Experiments were
performedwith fresh isolated PBMC, containing primary lymphocytes
and monocytes. While good infection was observed in CD14 positive
cells (monocytes) using VSV-G envelope as a control with 8.8% of cells
were GFP positive, little signiﬁcant infection (1% of cells were GFP
positive) was seen with the same backbone and CHIKV envelope.
Naturally occurring CHIKV variants carrying an alanine to valine
change in E1 (A226V) have been described to alter vector speciﬁcity
by increasing infectivity for the A. albopictus mosquito (Tsetsarkin
et al., 2007; Vazeille et al., 2007). Whether this change has any
effect in the ability of the virus to infect the mammalian host has not
previously been addressed. We therefore compared the infectivity of
both wild type and E1 A226V mutant pseudoparticles in different
mammalian cell lines. Input was normalized by p24 ELISA analysis
prior to infection so that the different cell lines were challenged with
equal amounts each pseudotype. Statistical analysis showed no
signiﬁcant difference (PN0.3) in infectivity between CHIKV envelopevariants in any of the cell lines tested (Fig. 4). This result indicates
that the presence or absence of the change A226V in CHIKV E1 gp
does not affect the gross ability of pseudotypes to infect mammalian
cells, although we cannot rule out the possibility of changes in the
kinetics of infection.
Mutations in E1 glycoprotein mediate cellular tropism differences in
mosquito cells
As lentiviral pseudotypes were not sufﬁciently infectious in
mosquito cells we decided to pseudotype VSV with CHIKV envelope
to determine the effect of the A226V mutation in mosquito cell entry.
Both A. albopictus cell lines and A. aegypti primary cells were tested for
susceptibility to CHIKV pseudotyped VSV. Again, parallel infections
were carried out with VSV particles produced in the absence of a viral
envelope protein as a negative control and VSV-G pseudotyped
particles to distinguish from possible post-entry blockage effects.
Using particles ﬁrst normalized by titering on RD cells, the infectivity
of VSV pseudotypes bearing the CHIKV envelope 226V mutation was
higher by more than 4 fold in C6/36 and 2 fold in C7–10 A. albopictus
cell lines when compared to wild type envelope pseudotypes (Fig.
5A). These subtle differences were statistically signiﬁcant (Pb0.05) in
multiple independent experiments using different batches of pseu-
dovirions, and demonstrate a role for this E1 mutation in virus
Fig. 5. Pseudotype infectivity for CHIKV envelope variants in mosquito cells. VSV
pseudotypes bearing CHIKV envelope wt (Black bars) or 226V mutant (Grey bars) were
titrated in parallel in (A) A. albopictus cell lines C6/36 and C7–10 and RD cells. Four
replicates were performed for each pseudotype. (B) A. aegypti cells and RD cells. Each
pseudotype was tested in triplicate. GFP titer was determined by ﬂow cytometry. Error
bars represent standard deviations (SDs). Differences in viral titers were analyzed by
pairwise t-tests. Diamond indicates Pb0.3. Dot indicates Pb0.05.
Fig. 6. DC-SIGN and DC-SIGNR enhance infectivity of CHIKV envelope glycoprotein-
bearing pseudotypes in 293T-REx cell lines. The data are presented as fold-
enhancement of infection in lectin expressing 293T-REx cells compared to parental
293T-REx cells. Error bars indicated standard deviations (SDs) of triplicate values from
a representative experiment. Similar results were obtained in three independent
experiments.
37B. Salvador et al. / Virology 393 (2009) 33–41binding/entry giving CHIKV 226V a selective advantage in A.
albopictus cells. However, no such advantage is detected in A. aegypti
cells since no differences in infectivity were observed between CHIKV
wild type and 226V mutant in three independent experiments
(Fig. 5B). The differences in CHIKV infectivity between C6/36 and
C7–10 cell lines observed in Fig. 5A are not speciﬁc since similar
differences were observed with the control VSV-G enveloped
pseudotypes (8.6×103 FFU/ml in C6/36 and 1.3×105 FFU/ml in
C7–10). No pseudotype induced cytopathic effects were observed
after 24 h when the analyses were performed.
CHIKV pseudovirion infectivity is enhanced by the presence of
C-type lectins
C-type lectins like DC-SIGN and DC-SIGNR have been shown to
augment infection of many viruses by interacting with the envelope
viral gps (Lozach et al., 2007), playing an important role in virus
transmission, tissue tropism, and pathogenesis. To determine the role
of lectin expression on the infectivity of CHIKV pseudotypes, we
utilized a previously reported 293T-REx cell line system, in which
lectin expression was under the control of a tet repressor protein that
allows induction of expression with doxycycline (Pohlmann et al.,
2001). The induction of lectin expressionwas veriﬁed by ﬂuorescence-
activated cell sorter staining (Supplementary Fig. 2) and Western blot(data not shown). We challenged the lectin expressing 293T-REx cells
with luciferase reporter pseudotypes bearing CHIKV envelope
glycoproteins. Ebola Zaire (EboZ-GP) envelope and VSV-G pseudo-
types, whose infectivity is respectively enhanced and unaffected by
the presence of lectins (Simmons et al., 2003) were used as positive
and negative controls. Infectivity of EboZ-GP envelope pseudotypes
was enhanced over 35-fold in DC-SIGN-expressing 293T-REx cells and
26-fold in DC-SIGNR expressing cells, compared with the parental
293T-REx cells (Fig. 6). Similarly, the infectivity of CHIKV envelope
pseudotypes was enhanced over 10-fold in DC-SIGN-expressed 293T-
REx cells and 19-fold in DC-SIGNR expressed cells (Fig. 6). In contrast,
VSV-G infection of either DC-SIGN or DC-SIGNR expressing cells was
within 2-fold of parental 293T-REx cell infection. Enhancement of
CHIKV pseudotypes infectivity was also observed in susceptible HeLa
and RD cell lines expressing DC-SIGN and DC-SIGNR (data not shown).
While expression of DC-SIGN on already susceptible cell lines
enhanced infection, refractory lines, such as B-THP-1, NC-37 and
Ramos cell lines, remained resistant to infection, despite stable DC-
SIGN expression (data not shown).
Discussion
CHIKV characteristics and the widespread distribution of its
mosquito vectors make it a potentially highly important emerging
pathogen. However, very little is known about the biology of this
alphavirus, although its similarity to other alphaviruses suggests
general principles that may govern its biological activities. The
envelope proteins are the major determinants of alphavirus cell
tropism, viral entry and neutralization sensitivity. With the advance-
ment of molecular technologies, several pseudotype reporter viral
systems have been developed for different enveloped viruses making
the investigation of phenotypic properties of envelope proteins more
convenient and efﬁcient (Bartosch et al., 2003; Chan et al., 2006;
Fukushi et al., 2005; Ma et al., 1999; Matsuura et al., 2001; Rollman et
al., 2007; Simmons et al., 2004; Wool-Lewis and Bates, 1998).
We have successfully exploited the cell surface expression of
CHIKV proteins in transfected cells to produce lentiviral particles that
are able to transduce cells in a CHIKV envelope-mediated manner. The
infectivity of these pseudotyped reporter viruses in CD4 and CXCR4
negative cell lines (Table 2) with a single round of infection, indicates
that the CHIKV envelope is directing entry, thus broadening the cell
tropism of the resulting HIV particles. CHIKV gps are not only
efﬁciently produced and expressed on the cell surface but are also
incorporated in the pseudotyped viruses. Although E1 and E2 proteins
38 B. Salvador et al. / Virology 393 (2009) 33–41migrate closely on gels (Sourisseau et al., 2007) and could not be
distinguished by size due to heterogeneous glycosylation, the fact that
correct E2 processing requires E1 coexpression makes it likely that
both proteins are being expressed. Furthermore, CHIKV pseudovirions
present native epitopes on their surfaces that are recognized by
neutralizing human sera from individuals previously infected with
CHIKV. CHIKV pseudotypes enter cells through a pH-dependent
pathway, being readily blocked by three inhibitors of endocytic
acidiﬁcation as described for CHIKV (Sourisseau et al., 2007). Thus,
CHIKV lentiviral pseudotypes offer the potential to rapidly and easily
study native entry pathways of the parental CHIKV in the absence of
other cytotoxic effects associated with alphavirus infection.
The host range conferred by CHIKV envelope is very broad,
enabling the infection by CHIKV pseudotypes of a variety of cell lines
from diverse species and tissues. The infection of many of the cell
types used for this work is not unexpected as CHIKV displays a rather
wide tropism and has been shown to infect a variety of human and
non-human cell types (Glasgow, 1966; Hahon and Zimmerman, 1970;
Ozden et al., 2007; Rinaldo et al., 1975; Simizu et al., 1984; Sourisseau
et al., 2007). Interestingly, human cell lines A549 and U937, recently
described as resistant to CHIKV infection (Sourisseau et al., 2007) are
susceptible to infection by CHIKV lentiviral pseudotypes. These
results, together with the fact A549 cells are able to bind CHIKV
virions (Sourisseau et al., 2007), indicate that the restriction to CHIKV
replication in these cells occurs at a post-entry step of viral infection.
The exception for CHIKV pseudotypes susceptibility was hematopoie-
tic cell lines, most of which were partially or completely refractory to
the infection (Table 2 and Fig. 3). Similar results have been described
for replication competent CHIKV, as well as pseudovirions bearing
envelopes from the related alphaviruses RRV and SFV (La Linn et al.,
2005; Strang et al., 2005). We believe that the failure to transduce
those cells is most likely due to the lack or limited expression of the
cellular receptor(s), or cellular events involved in internalization,
given the efﬁciency of transduction by VSV-G pseudotypes. These
results suggest that CHIKV receptor(s) are present in different host
species and thus CHIKV envelope provides a broad speciﬁcity to the
pseudotyped vectors. Susceptibility of some cell types to Ebola virus
has been described to be affected by cell adhesion properties (Dube
et al., 2008). Our results show that the differences in CHIKV
pseudotypes infectivity between adherent and non-adherent cells
are independent of the anchorage-dependency of the cells. The
refractory hematopoietic cell types may be useful for receptor
identiﬁcation. The fact that partially refractory THP1 monocytes
increase their susceptibility upon differentiation to macrophages,
most likely by induced expression of the virus receptor, makes cells of
the monocyte/macrophage lineage potential candidates in aiding the
discovery of the CHIKV cell surface receptor(s).
The use of CHIKV pseudotypes also provides a straightforward tool
for the functional characterization of envelope gps variants. Single
amino-acid changes in CHIKV gps such as E1 A226V have been
described to affect virus speciﬁcity (Tsetsarkin et al., 2007; Vazeille
et al., 2007). Moreover, adaptation of CHIKV 226V to A. albopictus
mosquitoes coincides with CHIKV dependence on cholesterol in the
target cell membrane (Tsetsarkin et al., 2007). Similarly, a mutation in
the same position of the E1 gp from SFV has been described to affect
the cholesterol dependency of the virus (Vashishtha et al., 1998) and,
unlike CHIKV (Tsetsarkin et al., 2007), results in the more efﬁcient
growth of SFV in A. albopictusmosquitoes (Ahn et al., 1999). Whether
there is direct correlation between the release from the cholesterol
dependence, and the growth advantage in A. Albopictus remains
unknown. As expected, we have found no effect of E1 A226V
mutation in CHIKV pseudotypes infectivity in mammalian cells.
However, the presence of the mutation increases CHIKV pseudotypes
infectivity in A. albopictus cells from 2 to 4 fold but has no effect in A.
aegypti cells. These results demonstrate a direct effect of the mutation
in the CHIKV entry process resulting in differences in cellular tropism.Although both are derived from Singh's original larva isolates (Singh
and Pavri, 1967), several reports suggest differences between C6/36
and C7–10 A. albopictus subclones indicating that they may represent
different tissue types in the adult insect (Condreay and Brown, 1986,
1988; Miller and Brown, 1992, 1993). Thus, it may be that the 226V
change confers a selective advantage in multiple cell types within A.
Albopictus. Despite the demonstrated ﬁtness advantage of E1 226V
virus in A. albopictus mosquitoes, almost indistinguishable growth
kinetics of CHIKV 226A and 226V viruses in A. albopictus C6/36 cells
have been described (Tsetsarkin et al., 2007). While this appears to be
somewhat contradictory to our results that show that the E1 226V
CHIKV pseudotype entry in A. albopictus cells C6/36 and C7–10 is
subtly more efﬁcient than the wild type, multiple rounds of
replication and post-entry steps of the virus life cycle likely conceal
this difference and result in almost equivalent growth kinetics. A
putative role for E1 226 position in membrane fusion is consistent
with its predicted location in the ij loop, a region believed to interact
with the target membrane, in contact with the fusion peptide
(Schuffenecker et al., 2006). However, we cannot rule out additional
implications of the E1 A226V mutation in other steps of the virus life
cycle like virus budding and exit. Whether this more efﬁcient entry of
the virus is enough to account for the ﬁtness advantage of the E1
226V mutant in A. albopictus mosquitoes and its possible association
with cholesterol dependence requires further investigation. CHIKV
pseudotypes will facilitate the study of the effect of cholesterol in
virus entry independently of the post-entry steps.
Our results suggest that C-type lectins act as CHIKV attachment
factors and increase infectivity. DC-SIGN and DC-SIGNR lectins bind
virus envelope proteins in a carbohydrate-dependent manner, and are
likely recognizing high mannose moieties on the viral gps, which
contain at least four predicted N-linked glycosylations (asn-X-ser/thr,
where X can be any aa apart from proline; Hubbard and Ivatt, 1981). In
mouse models of CHIKV infection the liver represents a strong initial
target for viral replication, followed by detection of virus in muscle
and skin (Couderc et al., 2008). Consistent with this, CHIKV
pseudotypes efﬁciently infect (1.9×105 FIU/ml) Huh7 human hepatic
cell line. The expression of DC-SIGN and DC-SIGNR, as well as other C-
type lectins, in the liver (Lai et al., 2006; Pohlmann et al., 2001) may
thus be involved in the early targeting of this organ, while C-type
lectins on macrophages and dendritic cells may be involved in
disseminating the virus to other tissues.
In this study, we have successfully established retrovirus and
rhabdovirus-based pseudotype reporter assays for CHIKV, which to
our knowledge, are the ﬁrst viral reporter systems described for
CHIKV. Our results indicate that CHIKV pseudotypes accurately mimic
the entry mechanism of the virus and offer a stable and safe source of
native antigen thus providing an ideal system for CHIKV immune
response analysis, glycoproteins function determination, entry studies
and receptor identiﬁcation. Moreover we have established that
mutations in E1 glycoprotein affecting CHIKV entry efﬁciency mediate
alterations in cellular tropism.
Materials and methods
Cells and cell culture
Adherent mammalian cell lines were cultured in DMEM and non-
adherent cells were cultured in RPMI, in both cases media was
supplemented with 10% FBS and penicillin/streptomycin (15 U/ml).
Human endothelial cells (Clonetics) were cultured in Clonetics
endothelial cell basal media and human keratinocytes (Clonetics)
were cultured in Clonetics keratinocyte cell basal media-2. Human
primary blood lymphocytes (PBLs) were isolated as previously
described (Simmons et al., 1995) and stimulated in RPMI 1640
containing 20% FCS and 0.5 μg/ml phytohaemagglutinin (PHA, Roche).
After 3 days of culture, the cells were spun and resuspended in RPMI
39B. Salvador et al. / Virology 393 (2009) 33–411640 containing 20% FCS and 20 U/ml human interleukin-2 (IL-2,
Roche). Human primary monocytes were isolated from donors by
apheresis and elutriation. Human primary monocyte-derived macro-
phages were isolated as previously described (Simmons et al., 1995)
and cultured in RPMI supplemented with 10% human serum and
penicillin/streptomycin (15 U/ml). The C7–10 A. albopictus cell line
was kindly provided by Victor Stollar (UMDNJ), while C6/36 were
obtained from the ATCC. C7–10 and C6/36 were cultured in MEM
supplemented with 10% FBS and penicillin/streptomycin (15 U/ml)
while A. aegypti cells (ATCC CCL-125) were cultured in MEM
supplemented with 20% FBS and penicillin/streptomycin (15 U/ml).
Fetal muscle cells were obtained from elective abortions with the
approval of the Committee for Human Research at the University of
California, San Francisco and consent of the women undergoing the
procedure. The gestational age of the tissues was estimated based on
the foot-length of the fetus and ranged from 19 to 24 weeks. Fetal
tissues were harvested shortly after termination of the pregnancy and
transported to the laboratory on ice in Hank's balanced salt solution
with calcium andmagnesium (HBSS) and supplementedwith 100 μg/
ml gentamicin and 2.5 μg/ml amphotericin B (Invitrogen, Carlsbad,
CA). Muscle cells were isolated from tongue or thigh muscles and
grown similarly to a previously described method (Ozeki et al., 2006).
Brieﬂy, the tissue was washed with HBSS solution and, in the case of
thighmuscles, the skin removed and themuscle tissue separated from
the bone. The tissues wereminced using scissors into pieces≤0.5 cm3.
These fragments were digested using a combination of 1% collagenase
class D, 2.4 U/ml grade II Dispase and 0.005% DNase (Roche Diagnostic
Corporation, Indianapolis, IN) in 20 ml of HBSS for 30–45 min at 37 °C
with gentle agitation. The cell suspension was then passed through a
ﬁne wire mesh and any remaining larger fragments disrupted using a
glass pestle. The resulting cell suspension was then passed through a
70 m cell strainer (BD Biosciences) to remove any remaining tissue
fragments. Cells were washed twice by centrifugation. Muscle cells
were cultured on Laminin-1 coated dishes (BD Falcon) in F-10
medium (Invitrogen) supplemented with 20% FBS, 2 μg/ml recombi-
nant human insulin (Roche Diagnostic Corporation), 50 μg/ml
gentamicin and 2.5 μg/ml amphotericin B. Staining of cultured muscle
cells was performed with CD146-PE (clone 128018, R&D Systems).
CD146 is a marker of fetal myoblasts (Cerletti et al., 2006).
For the 293T-REx cell lines, DC-SIGN and DC-SIGNR were
expressed under a tet repressor (Invitrogen) and grown in DMEM
medium containing 10% FBS, Zeocin (50 μg/ml), and blasticidin
(2.5 μg/ml) as described (Pohlmann et al., 2001). The 293T-REx
parental cells were maintained in DMEMmedium containing 10% FBS
and blasticidin (2.5 μg/ml). Lectin expressionwas induced by addition
of 0.1 μg/ml of doxycycline to the medium.
Both true THP-1 cells, a monocyte cell line (ATCC TIB-202), and B-
THP-1 cells were used. B-THP-1 have been shown to be a B cell line,
probably derived from Raji cells, that werewrongly classiﬁed as THP-1
cells (Wu et al., 2004).
Plasmids
Human codon optimized CHIKV E3/E2/E1 was synthesized
(Integrated DNA Technologies, Coralville, IA) based on the structural
polyprotein sequence for the S27 African prototype strain of CHIKV
(Khan et al., 2002). Assuming an amino-acid numeration of 1 for the
initiating methionine of capsid protein, an expression cassette for E3/
E2/E1 was synthesized consisting of amino acids 262 to 1248,
together with an initiating ATG and upstream Kozak sequence. This
was subcloned into the mammalian expression plasmid, pCAGGS
(Niwa et al., 1991) using SacI and NheI. A naturally occurring A226V
mutation in E1 was introduced using Quikchange site directed
mutagenesis (Stratagene) in pUC57 CHIKV E3/E2/E1. A 750 bp
fragment carrying the change was swapped into pCAGGS CHIKV E3/
E2/E1 and conﬁrmed by sequencing. Plasmids expressing Ebola Zaire(EboZ), vesicular stomatitis virus (VSV), and amphotropic murine
leukemia virus (MLV-A) glycoproteins have been described (Simmons
et al., 2002).
Pseudotype production
Lentiviral pseudotypes were produced essentially as described
(Simmons et al., 2004) by using 10 μg of luciferase, GFP, or murine
CD24 vector (pNL-luc, pNL-gfp, or pNL-HSA based on pNL3-4-R-E-)
(Connor et al., 1995) and 30 μg of plasmid-encoding viral envelope.
Pseudotyped VSVs were produced essentially as described by
Matsuura et al. (2001) by transfecting 293T cells with 16 μg of
plasmid-encoding viral envelope and then infecting the cells with
recombinant VSVΔG⁎-G kindly provided by Dr. Whitt (University of
Tennessee) at 0.1 multiplicity. If required, virions were concentrated
by ultracentrifuge concentration at 28,000 rpm in a SW28 rotor
(Beckman) through a 20% sucrose cushion for 1.5 h at 4 °C. The pellets
were resuspended overnight in HBSS at 4 °C.
Pseudovirion infection
After p24 ELISA (Aalto BioReagents, Dublin, Ireland) analysis,
lentiviral pseudovirions were normalized to contain an equal number
of viral particles. Cells were seeded at 2.5×104 in 48-well plates 24 h
prior to infection. Appropriate amounts of viral supernatant in 200 μl
of mediumwere added to the plates prior to spin infection (Simmons
et al., 2002) for 1.5 h at 2100 ×g at room temperature. After a 2 h
incubation at 37 °C, 300 μl of fresh mediumwas added and cells were
incubated for 72 h. Virus infection was analyzed by measuring the
number of GFP expressing cells either by counting green cells using
ﬂuorescence microscopy or by ﬂow cytometric analysis. For VSV
pseudotype infectionmosquito cells were seeded at 1×105 cells in 48-
well plates 24 h prior to infection. Appropriate amounts of viral
supernatant in 200 μl of medium were added to the plates and
incubated for 24 h at 28 °C. Virus infectionwas analyzed bymeasuring
the number of GFP expressing cells by ﬂow cytometric analysis.
Neutralization of pseudovirions was performed by using sera from
CHIKV infected individuals (kindly supplied by Azzedine Assal, EFS
Centre-Atlantique, France and Robert S. Lanciotti, Centers for Disease
Control and Prevention, Fort Collins). Luc pseudovirions were
pretitrated on 293T cells to ensure similar input levels of viruses.
Sera was inactivated at 56 °C, serially diluted and mixed with luc
reporter pseudovirions at a 1:1 ratio and incubated for 45min at room
temperature before addition of 50 μl to RD cells seeded at 2×104 cells
per well in 96-well plates. After spin infection for 1 h at 1600 ×g, cells
were incubated for 2 h at 37 °C, washed twice and incubated for 40 h.
Luciferase activity was assayed from cell lysates as per manufacturer's
instructions (Promega).
Immunological detection of CHIKV envelope glycoproteins
293Tcells were transfected as for pseudotype production. The cells
were lysed 40 h post-transfection using RIPA buffer, the cell lysate
sonicated to shear the DNA and then centrifuged at 2500 ×g for 20min
at 4 °C to pellet cell debris. The supernatant was collected and
concentrated as described for pseudotype production. Sample buffer
and reducing agent were added to the cell lysates and concentrated
pseudovirions and the samples were the analyzed by SDS-PAGE using
an 8% Bis–Tris gel (Invitrogen). The separated proteins were
transferred to a nitrocellulose membrane and blocked with 2%
powderedmilk in TBS for 30min at room temperature. Themembrane
was then incubated in TBS-0.05% Tween-20 with a 1:200 dilution of a
mix of heat-inactivated sera from CHIKV infected individuals for 1 h at
room temperature. After 3 washes, 10 min each, with TBS-0.05%
Tween-20 the membrane was incubated with 1:200 dilution of Alexa
488 goat anti-human antibody (Invitrogen) for 1 h at room
40 B. Salvador et al. / Virology 393 (2009) 33–41temperature. The membrane was then washed with TBS-0.05%
Tween-20 three times for 10 min each, and immunoreactive proteins
were visualized using a Molecular Dynamics Storm 860 imaging
system in blue ﬂuorescence mode.
Lysosomotropic agents
Cells were incubated with serial dilutions of baﬁlomicin A,
chloroquine, or NH4Cl (Sigma) 1 h before and during spin infection
with Luc pseudovirions. The agent was included in the medium for 5 h
after infection, before replacement with fresh medium and assaying
for transduction 70 h after infection.
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